OMI heads north again
Thursday, 31 July, 2008
Occupational and Medical Innovations [ASX: OMI] has found a Canadian distribution partner for its auto-retractable safety syringes.
OMI has granted Domrex Pharma exclusive rights to distribute the syringes in Canada, but OMI's pre-existing deal granting Cardinal Health distribution rights in Canada will still be honoured.
The deal will last three years, and will be extended if minimum sales targets are met.
The safety syringes have yet to be approved for sale in Canada, but OMI expects to obtain regulatory approvals in late August or early September.
OMI announced yesterday that the Federal Court of Australia had found that its syringe device did not infringe the patent of US competitor Retractable Technologies (RTI).
RTI is also suing Becton Dickinson (BD) in the US for patent infringement.
Hormone therapy shifts body proteins to match gender identity
Researchers have discovered that gender-affirming hormone therapy can alter body proteins to...
Targeting 'molecular bodyguards' weakens prostate cancer cells
Research reveals that two enzymes — PDIA1 and PDIA5 — act as 'molecular...
Females found to carry a higher genetic risk of depression
An international team of scientists has discovered about twice as many genetic 'flags'...
